Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Starting on:
Oct 29, 2024
Ending on:
Oct 29, 2024
Moderator(s):
Dr. Zeph Oyugi
ECASACOP RESIDENT
Venue:

Max Credits:
3 Points

Provider:
The Mater Hospital
Claim Points

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Starting on:
Oct 29, 2024
Ending on:
Oct 29, 2024
Venue:

Description

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Objectives

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Presenters

  1. Dr. Stephen Thigu
    ECSACOP RESIDENT
    The Mater Hospital

  2. Dr. Enoch Omonge
    Consultant Physician
    The Mater Hospital

Search For CPD Activity